搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
CBS19 News
1 小时
Virginia Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Daily Journal
2 小时
Franciscan doctors to host discussion on weight-loss drugs, health
A special event is aimed at answering questions and giving local residents the best information about those medications.
KSJB AM
2 小时
U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...
The Manhattan Mercury
3 小时
Kansas Residents Are Using GLP-1s at an Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
6 小时
What are your questions about weight loss drugs?
Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...
6 小时
‘This Weight Loss Drug Helped My Mental Health Way More Than Any Other Medication’
The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental ...
10 小时
Dave Ricks
Dave Ricks became CEO of Eli Lilly in 2017, but has been working at different departments within the company since 1996. The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈